Paid Clinical Trials Nashville

Discover 830 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 830

BMS-986340, Nivolumab, DocetaxelA Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

Bristol-Myers Squibb

Location:

Nashville TN, Iowa City IA, Hamilton, Torontoshow 11 more

Code:

NCT04895709

Conditions

Cervical Cancer

Gastric/Gastroesophageal Junction Adenocarcinoma

Microsatellite Stable Colorectal Cancer

Non-Small-Cell Lung Cancer

Squamous Cell Carcinoma of Head and Neck

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BMS-986340

BMS-936558-01

Docetaxel

Investigational CMV Vaccine Study for Volunteers Ages 9–15Investigational CMV Vaccine Study for Volunteers Ages 9–15

PHASE1

PHASE2

Sponsor:

Moderna

Location:

Nashville TN, Birmingham AL, Chamblee GA, Atlanta GAshow 43 more

Code:

NCT05575492

Conditions

Cytomegalovirus

Eligibility Criteria

Sex: All

Age: 9 - 15

Healthy Volunteers: Accepted

Interventions

mRNA-1647

Placebo

FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors

Recruiting

PHASE1

Sponsor:

Fate Therapeutics

Location:

Nashville TN, Cincinnati OH, Saint Louis MO, Columbus OHshow 10 more

Code:

NCT06241456

Conditions

Advanced Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

FT825

Fludarabine

Cyclophosphamide

Bendamustine

Docetaxel

RRMMMMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM

Recruiting

PHASE2

Sponsor:

Multiple Myeloma Research Consortium

Location:

Nashville TN, Atlanta GA, St. Louis MO, Charlotte NCshow 7 more

Code:

NCT06171685

Conditions

Relapse Multiple Myeloma

Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Teclistamab Monotherapy

Teclistamab

Alisertib & Endocrine TherapyA Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

Recruiting

PHASE2

Sponsor:

Puma Biotechnology, Inc.

Location:

Nashville TN, Birmingham AL, Atlanta GA, Saint Louis MOshow 18 more

Code:

NCT06369285

Conditions

Hormone Receptor Positive HER-2 Negative Breast Cancer

Metastatic Breast Cancer

Recurrent Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Alisertib

Endocrine therapy

Aseptic Pleural EffusionThe ACES Study for Aseptic Pleural Effusion

Recruiting

Sponsor:

Pleural Dynamics, Inc.

Location:

Nashville TN, Chapel Hill NC, Baltimore MD, Hollywood FL

Code:

NCT06210685

Conditions

Pleural Effusion

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Automatic Continuous Effusion Shunt implantation

CFT1946A Study to Characterize the Safety, Tolerability, and Preliminary Efficacy of CFT1946 As Monotherapy and Combination Therapy in Subjects with BRAF V600 Mutant Solid Tumors

Recruiting

PHASE1

PHASE2

Sponsor:

C4 Therapeutics, Inc.

Location:

Nashville TN, Indianapolis IN, St. Louis MO, Madison WIshow 7 more

Code:

NCT05668585

Conditions

Solid Tumors

Melanoma

NSCLC

CRC

ATC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CFT1946

Trametinib

Cetuximab

Genetic RegistryParkinson's Foundation PD GENEration Genetic Registry

Recruiting

Sponsor:

Parkinson's Foundation

Location:

Nashville TN, Lexington KY, Atlanta GA, Cincinnati OHshow 35 more

Code:

NCT04994015

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Lab Assay for seven genetic variants for Parkinson's Disease

PsychotherapyVolatility in Paranoia (VIP) Trial: An RCT of Changes in Volatility With Psychotherapy

Recruiting

Sponsor:

Vanderbilt University Medical Center

Location:

Nashville TN

Code:

NCT06835556

Conditions

Schizophrenia Disorders

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Cognitive Behavioral Therapy

TAU

Observational StudyStorage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

Recruiting

Sponsor:

Vanderbilt-Ingram Cancer Center

Location:

Nashville TN

Code:

NCT01205815

Conditions

Melanoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Tissue and blood collection

VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body

Recruiting

Sponsor:

Bayer

Location:

Multiple Locations, Nashville TN, Memphis TN, Terre Haute INshow 42 more

Code:

NCT04142437

Conditions

Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

larotrectinib(Vitrakvi, BAY2757556)